Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Renewi Plc
-
Wearable Devices Unveils the LLM of Gesture Control: Large MUAP Models (LMM) Set to Revolutionize Human-Computer Interaction
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Shares for Interest Debt Settlement
-
Northfield Capital Announces Changes to the Board of Directors
-
DDB Miner Expands Cloud Mining Solutions, Offering Users a Path to Financial Freedom
-
Scleroseforeningen choose Agillic for personalised member engagement and community impact
-
Topicus.com Inc. announces Shareholders’ Agreement
-
Digihost Provides January 2025 Production Update
-
FTI Consulting Announces Technology Alliance with iManage
-
TILT Holdings Signs Definitive Agreement to Divest Retail Locations in Massachusetts to In Good Health for $2 Million
-
BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™
-
American Tungsten Corp. Strengthens Strategic Position as Domestic Tungsten Supplier Amid U.S.-Canada Tariffs
-
Tyson Foods Reports First Quarter 2025 Results
-
NFI schedules fourth quarter and full year 2024 financial results
-
Itafos Continues With Outstanding Operational Performance, Provides Q4 2024 Operational Update
-
OREA presents ten bold housing solutions for the 2025 provincial election
-
Safe Harbor Financial Announces Temporary Pause in Principal Payments and Ongoing Discussions to Modify Promissory Note with PCCU
-
nCino Announces Appointment of Sean Desmond as President and Chief Executive Officer
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Saia Reports Fourth Quarter Results
-
Fingerprint Cards AB (Fingerprints) partners with leading advisory firm to grow IP commercialization and defend its technology
-
STAKING NOW AVAILABLE IN THE UK, UPHOLD RELAUNCHES SERVICE TO USERS
-
Outbrain Completes the Acquisition of Teads
-
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
-
IREN to Release Q2 FY25 Results on February 12, 2025
-
Allegro MicroSystems Appoints Dr. Krishna Palepu to its Board of Directors
-
uniQure Announces Completion of Enrollment in the First Cohort and Favorable Recommendation from the Independent Data Monitoring Committee for its Phase I/IIa Clinical Trial of AMT-191 for the Treatme
-
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
-
Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
-
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
-
Emerita’s 2024 Year in Review and Strategic Outlook for 2025
-
Brandywine Realty Trust and FS Investments Announce FS’s New Global Headquarters at Schuylkill Yards
-
Introducing HRCI ENGAGE, A Global Online Community for HR Professionals to Connect and Share Insights
-
Fury Commences 2025 Drilling Program at the Éléonore South Gold Project
-
Hemlo Explorers Announces Change in Management and Name Change to Rocky Shore Gold Ltd.
-
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
-
Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
-
Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
-
Brunswick Exploration Reports Phase 1 Metallurgical Results at Mirage with Potential for DMS-Only Flowsheet
-
FinLogic Quantitative Think Tank Center Led by Charles H. Sloan Innovates Investment Strategies
-
Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform
-
PyroGenesis’ Contract with Varennes Carbon Recycling Plant Project Increases to $3.6 million.
-
Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Bitfarms Provides January 2025 Production and Operations Update
-
LeddarTech Enters Into Amendments to Credit Facility and Bridge Financing Offer
-
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
-
Lavoro Reports Fiscal First Quarter 2025 Earnings Results
-
Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population
